Auris Medical Holding Ltd - ESG Rating & Company Profile powered by AI
This dashboard contains a Q&A section about Auris Medical Holding Ltd. This page contains a zero-cost Environmental, Social and Governance report covering Auris Medical Holding Ltd. This analysis of Auris Medical Holding Ltd employs intelligence from across the web as well as from available documents by Auris Medical Holding Ltd.
Auris Medical Holding Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.9; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.7.
0.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1810 | XBiotech Inc | 1.1 | Low |
1826 | Mitsubishi Tanabe Pharma Corp | 1.0 | Low |
1827 | Auris Medical Holding Ltd | 0.9 | Low |
1827 | CannTrust Holdings Inc | 0.9 | Low |
1827 | Cannabis Poland SA | 0.9 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Auris Medical Holding Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Auris Medical Holding Ltd report the average age of the workforce?
Sign up for free to unlockDoes Auris Medical Holding Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Auris Medical Holding Ltd offer flexible work?
Sign up for free to unlockDoes Auris Medical Holding Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Auris Medical Holding Ltd conduct supply chain audits?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Auris Medical Holding Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose water use targets?
Sign up for free to unlockDoes Auris Medical Holding Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Auris Medical Holding Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Auris Medical Holding Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Auris Medical Holding Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Auris Medical Holding Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Auris Medical Holding Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Auris Medical Holding Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose its waste policy?
Sign up for free to unlockDoes Auris Medical Holding Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose energy use targets?
Sign up for free to unlockDoes Auris Medical Holding Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Auris Medical Holding Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Auris Medical Holding Ltd
These potential risks are based on the size, segment and geographies of the company.
Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, including OligoPhore and SemaPhore platforms that are in preclinical stage for oligonucleotide and mRNA delivery; AM-125 that is in Phase 2 of clinical development for the intranasal treatment of vertigo; Keyzilen, which is in Phase 3 of clinical development for the treatment of acute inner ear tinnitus; and Sonsuvi that is in Phase 3 of clinical development for the treatment of acute inner ear hearing loss. It operates primarily in Basel, Switzerland. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. Altamira Therapeutics Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda.